CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-03). The draft was written by AI, the existence of all 4 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 2095 · Search date 2026-08-03 · Methodology v0.6

Plant-based meat alternatives,
does it really help with Lower LDL cholesterol?

30-Second Summary
C
Evidence Grade C · 44 · Safety caution
LDL was lower than with animal meat, but product composition, funding, and short-term surrogate limits matter
These are ordinary foods, but sodium, saturated fat, and allergens vary by product. They should not replace cardiovascular treatment or lipid-lowering medication.
What the
research shows
The grade is C. SWAP-MEAT randomized 38 people, and 36 completed two eight-week periods of animal meat and plant-based alternatives. TMAO was the registered primary outcome and LDL was prespecified secondary. The adjusted LDL difference was -10.8 mg/dL (95% CI -17.3 to -4.3). Beyond Meat funded trial operations, and the principal investigator disclosed an unrestricted research gift from Beyond Meat. NHLBI training support and Stanford CTSA infrastructure did not jointly fund trial operations.
What the
ads claim
Plant-based does not automatically mean low sodium or low saturated fat. This tested meat analogs, not beans or tofu.
*

Useful facts when choosing a product

  • A representative 113-g Beyond Burger at the trial era had about 390 mg sodium, 0 g sugar, about 5 g saturated fat, 2 g fiber, and 20 g protein. Formulations and products change.
  • Some alternatives contain more sodium than unseasoned meat, and saturated fat depends on formulation oils.
  • Verdict 2074 is C with 45 points for red versus white meat and LDL; this verdict directly replaces animal meat with processed plant-based analogs.
Gap Measurement · Verdict 2095 · C 44
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Crimarco crossed at least two daily servings of Beyond Meat products with beef, pork, and chicken periods. Thirty-six of 38 randomized participants completed both eight-week phases. TMAO was primary in the registry and analysis plan; LDL was prespecified secondary. The paper states that Beyond Meat funded the study and that the principal investigator received an unrestricted research gift from Beyond Meat. NHLBI training support and Stanford CTSA infrastructure did not jointly fund trial operations.

02

Why this is classified as C (44)

One manufacturer-funded crossover trial found a conventionally moderate LDL difference, but it was a prespecified secondary surrogate without comparable independent replication and was small and short, giving C with 44 points.

Counterpoint. C does not mean the products are moderately heart-healthy; it describes limited evidence for the LDL claim.

Rejudgment record. Cross-check applied — Assessed registry outcomes, adjusted LDL difference, approximate standardized magnitude, later randomized evidence, pooling, and funding

Scoring profile behind this grade
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR1Single confirmatory trial
IndependenceI0Evidence comes only from manufacturer studies
Effect sizeE+Meets the clinically important threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Lower LDL versus animal meatCThe pooled direction was favorable, with surrogate, product-heterogeneity, and industry-funding limits.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Randomized crossover diet trial without washout36Beyond Meat trial funding and products; NHLBI training and Stanford CTSA infrastructure supportPrimary TMAO; prespecified secondary LDLLDL 109.9 plus or minus 4.5 versus 120.7 plus or minus 4.5 mg/dL; adjusted difference -10.8 (-17.3 to -4.3)Pivotal manufacturer-funded surrogate trial
Study 2Meta-analysis of adult randomized trials7Mixed funding across included trialsLDL cholesterolMD -0.25 mmol/L (95% CI -0.42 to -0.08), I-squared 65.8%Indirect pooled estimate mixing products and comparators
Study 3Eight-week randomized diet trial89Public fundingLDL cholesterolEight-week difference 0.0 mmol/L (95% CI -0.2 to 0.1)Indirect evidence not counted as direct replication or conflict because products and control design differed
§

Receipt — 4 References

All 4 cited sources were verified for existence at the original page (as of 2026-08-03).

Crimarco A, Springfield S, Petlura C, et al. A randomized crossover trial on plant-based compared with animal-based meat. Am J Clin Nutr. 2020;112:1188-1199. PMID: 32780794. DOI: 10.1093/ajcn/nqaa203.
checked
ClinicalTrials.gov. NCT03718988: SWAP-MEAT.
checked
Fernández-Rodríguez R, Bizzozero-Peroni B, Díaz-Goñi V, et al. Plant-based meat alternatives and cardiometabolic health: a systematic review and meta-analysis. Am J Clin Nutr. 2025;121:274-283. PMID: 39653176. DOI: 10.1016/j.ajcnut.2024.12.002.
checked
RE-MAP randomized trial report. PMCID: PMC9071457.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-03 · Corrections: none

Cite this verdict

Plant-based meat alternatives x lower LDL versus animal meat Evidence Grade C card
[Chamgap] Plant-based meat alternatives x lower LDL versus animal meat — Evidence Grade C·44. 4 cited sources checked. Source: https://chamgap.com/en/verdicts/heart/plant-based-meat-alternatives-ldl-reduction/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.